New Pharmacology of Ulcer Disease: Experimental and New Therapeutic Approaches
Sandor Szabo, Gyula Mózsik
Elsevier, Jan 1, 1987 - Peptic ulcer - 579 pages
New Pharmacology of Ulcer Disease presents a much-needed overview of pharmacological research relating to the etiology and pathophysiology of ulcer disease. Discussed are new drugs or groups of compounds in development, bridging the gap between ulcer research and clinical pharmacology. With an emphasis on key developments in ulcer pharmacology, this volume helps to clarify and illuminate the complex pathophysiology of ulcer disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Cotroi0118 fteeen the MembraneBound ATPDependent ms and I3ker Treatment in the Rat and Man 11 F TdmJ1FieglerTJdvorFMor6nLNagy1 Pay
26 temine Agonist8 and Antagonists
mess of Cimetidine to Prevent
12 other sections not shown
acetazolamide activity administration agents alkaline secretion animals antacid antisecretory antiulcer aspirin aspirin-induced atropine basal biochemical bismuth calcium carbenoxolone carbonic anhydrase chronic cimetidine Clin clinical compounds cysteamine cytoprotection De-Nol decreased dopamine dose-dependent doses drugs duodenal ulcer duodenum endoscopic erosions ethanol ethimizol experimental gastric acid gastric acid secretion gastric and duodenal gastric cytoprotection gastric damage gastric lesions gastric mucosal damage gastric secretion gastric ulcer Gastroenterology gastrointestinal H2-antagonists H2-receptor antagonists healing rate hemorrhagic histamine increased indomethacin induced inhibition of gastric inhibitory effect intragastric Javor mechanism metabolism mg/kg Mozsik Gy mucosal lesions mucosal PGs mucus omeprazole oral parietal cells peptic ulcer PGE2 PGI2 Pharmacol pharmacologic Physiol pirenzepine placebo pretreatment prevent prostaglandin prostaglandin E2 protective effect ranitidine receptors role Scand J Gastroenterol significantly somatostatin stimulation stomach stress studies sucralfate Szabo Table therapeutic therapy tion tissue trial ulcer disease ulcer healing ulcerogenic verapamil vitro